Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study - Concepedia

Concepedia

Publication | Closed Access

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study

230

Citations

7

References

2011

Year

Ahmet Gül, İlknur Tuğal-Tutkun, Charles A. Dinarello, Leonid L. Reznikov, Bahar Artım-Esen, Amer M. Mirza, Patrick J. Scannon, Alan M. Solinger

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1